Association Between Alopecia Areata and COVID-19: A Systematic Review

February 2022 in “ JAAD International ”

Rachel E. Christensen, Mohammad Jafferany

alopecia areata COVID-19 SARS-CoV-2 autoimmune disease hair loss dermatologic manifestation physical stress psychosocial stress stress

Studysummary This review suggests that alopecia areata may occur as a dermatologic manifestation of COVID-19, often appearing 1 to 2 months after infection; further research is needed to clarify this association.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on jaadinternational.org →

Discuss this study in the Community →

Research cited in this study

7 / 7 results

research Alopecia Areata: An Update on Etiopathogenesis, Diagnosis, and Management

290 citations , August 2021 in “Clinical Reviews in Allergy & Immunology”

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

research Mild-To-Moderate COVID-19 Is Not Associated With Worsening Of Alopecia Areata: A Retrospective Analysis Of 32 Patients

11 citations , May 2021 in “Journal of The American Academy of Dermatology”

This study found that mild-to-moderate COVID-19 was not associated with worsening in patients with pre-existing alopecia areata.

research New Onset of Alopecia Areata in a Patient with SARS-CoV-2 Infection: Possible Pathogenetic Correlations

32 citations , March 2021 in “Journal of cosmetic dermatology (Print)”

This letter to the editor discusses a potential link between new onset alopecia areata and SARS-CoV-2 infection, but reports no new clinical results.

research A Systematic Review of Dermatologic Manifestations Among Adult Patients With COVID-19 Diagnosis

10 citations , March 2021 in “Skin health and disease”

This review discusses dermatologic manifestations of COVID-19, highlighting the possibility that skin signs might be the initial indicators of infection, though it reports no new clinical results.

research Rapidly Progressive Alopecia Areata Totalis in a COVID-19 Patient, Unresponsive to Tofacitinib

14 citations , February 2021 in “Journal of the European Academy of Dermatology and Venereology”

This article reports a case of rapidly progressive alopecia areata totalis in a COVID-19 patient that did not respond to treatment with tofacitinib; no new clinical results are discussed.

research Italian Survey for the Evaluation of the Effects of Coronavirus Disease 2019 Pandemic on Alopecia Areata Recurrence

24 citations , February 2021 in “Dermatology and Therapy”

This study reported a significant relapse in alopecia areata among patients infected with COVID-19, possibly due to the infection's inflammatory response and stress from quarantine.

research Immune Privilege Collapse And Alopecia Development: Is Stress A Factor

51 citations , December 2017 in “Skin Appendage Disorders”

This review examines the literature on autoimmune hair loss disorders, highlighting the collapse of immune privilege and the potential role of neurogenic stress in this process, but reports no new clinical results.